62 related articles for article (PubMed ID: 15892261)
1. Inhibitory mechanisms of 1-(3-C-ethynyl-beta-D-ribopentofuranosyl)uracil (EUrd) on RNA synthesis.
Yokogawa T; Naito T; Kanda H; Takatori S; Takenaka K; Sasaki T; Matsuda A; Fukushima M; Kim HS; Wataya Y
Nucleosides Nucleotides Nucleic Acids; 2005; 24(3):227-32. PubMed ID: 15892261
[TBL] [Abstract][Full Text] [Related]
2. Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)-cytosine, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity.
Hattori H; Tanaka M; Fukushima M; Sasaki T; Matsuda A
J Med Chem; 1996 Dec; 39(25):5005-11. PubMed ID: 8960561
[TBL] [Abstract][Full Text] [Related]
3. Antitumor mechanisms and metabolism of the novel antitumor nucleoside analogues, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil.
Takatori S; Kanda H; Takenaka K; Wataya Y; Matsuda A; Fukushima M; Shimamoto Y; Tanaka M; Sasaki T
Cancer Chemother Pharmacol; 1999; 44(2):97-104. PubMed ID: 10412942
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor effect and mechanism of a novel multifunctional nucleoside, 3'-ethynylnucleoside, on human cancers].
Tanaka M; Tabata S; Matsuda A; Fukushima M; Eshima K; Sasaki T
Gan To Kagaku Ryoho; 1997 Feb; 24(4):476-82. PubMed ID: 9063487
[TBL] [Abstract][Full Text] [Related]
5. A crucial role of uridine/cytidine kinase 2 in antitumor activity of 3'-ethynyl nucleosides.
Murata D; Endo Y; Obata T; Sakamoto K; Syouji Y; Kadohira M; Matsuda A; Sasaki T
Drug Metab Dispos; 2004 Oct; 32(10):1178-82. PubMed ID: 15280220
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic mechanisms of new antitumor nucleoside analogues, 3'-ethynylcytidine (ECyd) and 3'-ethynyluridine (EUrd).
Kanda H; Takatori S; Matsuda A; Sasaki T; Tanaka M; Fukushima M; Wataya Y
Nucleic Acids Symp Ser; 1997; (37):137-8. PubMed ID: 9586037
[TBL] [Abstract][Full Text] [Related]
7. Nucleosides and nucleotides. 175. Structural requirements of the sugar moiety for the antitumor activities of new nucleoside antimetabolites, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and -uracil1.
Hattori H; Nozawa E; Iino T; Yoshimura Y; Shuto S; Shimamoto Y; Nomura M; Fukushima M; Tanaka M; Sasaki T; Matsuda A
J Med Chem; 1998 Jul; 41(15):2892-902. PubMed ID: 9667977
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor mechanisms of 3'-ethynyluridine and 3'-ethynylcytidine as RNA synthesis inhibitors: development and characterization of 3'-ethynyluridine-resistant cells.
Tabata S; Tanaka M; Endo Y; Obata T; Matsuda A; Sasaki T
Cancer Lett; 1997 Jun; 116(2):225-31. PubMed ID: 9215867
[TBL] [Abstract][Full Text] [Related]
9. The characterization of cell death induced by 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl) cytosine (ECyd) in FM3A cells.
Takatori S; Tsutsumi S; Hidaka M; Kanda H; Matsuda A; Fukushima M; Wataya Y
Nucleosides Nucleotides; 1998 Aug; 17(8):1309-17. PubMed ID: 9672699
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of a new antitumor ribonucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), differs from that of 5-fluorouracil.
Kazuno H; Shimamoto Y; Tsujimoto H; Fukushima M; Matsuda A; Sasaki T
Oncol Rep; 2007 Jun; 17(6):1453-60. PubMed ID: 17487404
[TBL] [Abstract][Full Text] [Related]
11. Chemical Screening Identifies EUrd as a Novel Inhibitor Against Temozolomide-Resistant Glioblastoma-Initiating Cells.
Tsukamoto Y; Ohtsu N; Echizenya S; Otsuguro S; Ogura R; Natsumeda M; Isogawa M; Aoki H; Ichikawa S; Sakaitani M; Matsuda A; Maenaka K; Fujii Y; Kondo T
Stem Cells; 2016 Aug; 34(8):2016-25. PubMed ID: 27090194
[TBL] [Abstract][Full Text] [Related]
12. Effects of D-glucosamine and 6-azauridine on nucleotide contents, 5-fluorouridine uptake, and cytotoxicity in TA3 mammary tumor cells.
Holstege A; Keppler D
J Natl Cancer Inst; 1986 Mar; 76(3):485-92. PubMed ID: 2419623
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of nucleobase-modified analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd).
Hrdlicka PJ; Jepsen JS; Nielsen C; Wengel J
Bioorg Med Chem; 2005 Feb; 13(4):1249-60. PubMed ID: 15670934
[TBL] [Abstract][Full Text] [Related]
14. Role of uridine triphosphate in the phosphorylation of 1-beta-D-arabinofuranosylcytosine by Ehrlich ascites tumor cells.
White JC; Hines LH
Cancer Res; 1987 Apr; 47(7):1820-4. PubMed ID: 3028615
[TBL] [Abstract][Full Text] [Related]
15. Cellular and biochemical mechanisms of the resistance of human cancer cells to a new anticancer ribo-nucleoside, TAS-106.
Shimamoto Y; Kazuno H; Murakami Y; Azuma A; Koizumi K; Matsuda A; Sasaki T; Fukushima M
Jpn J Cancer Res; 2002 Apr; 93(4):445-52. PubMed ID: 11985795
[TBL] [Abstract][Full Text] [Related]
16. Mode of action of 9-beta-D-arabinofuranosyladenine on the synthesis of DNA, RNA, and protein in vivo and in vitro.
Müller WE; Rohde HJ; Beyer R; Maidhof A; Lachmann M; Taschner H; Kahn RK
Cancer Res; 1975 Aug; 35(8):2160-8. PubMed ID: 1149031
[TBL] [Abstract][Full Text] [Related]
17. A critical role for uridine nucleotides in the regulation of deoxycytidine kinase and the concentration dependence of 1-beta-D-arabinofuranosylcytosine phosphorylation in human leukemia cells.
White JC; Capizzi RL
Cancer Res; 1991 May; 51(10):2559-65. PubMed ID: 2021937
[TBL] [Abstract][Full Text] [Related]
18. Anticancer mechanisms of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl) cytosine (ECyd, TAS-106).
Naito T; Yokogawa T; Kim HS; Futagami M; Wataya Y; Matsuda A; Fukushima M; Kitade Y; Sasaki T
Nucleic Acids Res Suppl; 2002; (2):241-2. PubMed ID: 12903195
[TBL] [Abstract][Full Text] [Related]
19. [1-(3-C-methyl-beta-D-ribofuranosyl)uracil-5'-phosphate--a terminator of RNA synthesis catalyzed by RNA polymerase from E. coli].
Aĭvazashvili VA; Mikhaĭlov SN; Padiukva NSh; Karpeĭskiĭ MIa; Bibilashvili RSh
Bioorg Khim; 1986 May; 12(5):708-10. PubMed ID: 2425815
[TBL] [Abstract][Full Text] [Related]
20. Anticancer molecular mechanism of 3'-ethynylcytidine (ECyd).
Wataya Y; Futagami M; Naito T; Uchikubo Y; Yokogawa T; Takenaka K; Kim HS; Matsuda A; Fukushima M; Kitade Y
Nucleic Acids Res Suppl; 2001; (1):233-4. PubMed ID: 12836350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
